Stability of measurement of the immature platelet fraction

Authors

  • Mary M. Ruisi,

    Corresponding author
    1. Division of Pediatric Hematology/Oncology, Platelet Disorder Center, New York Presbyterian Hospital/Weill Cornell Medical Center, New York
    • Division of Pediatric Hematology/Oncology, Weill Cornell Medical Center, 525 East 68th Street, P-695, New York, NY 10021
    Search for more papers by this author
    • Group Authorship Information: MR organized and analyzed the data and wrote the manuscript. BP reviewed the data and the manuscript. MW performed the statistical analysis. GV provided technical assistance with the blood samples. JB designed the study, recruited patients from the hematology clinic, and supervised the organization and writing process.

  • Bethan Psaila,

    1. Division of Pediatric Hematology/Oncology, Platelet Disorder Center, New York Presbyterian Hospital/Weill Cornell Medical Center, New York
    2. Department of Haematology, Division of Investigative Sciences, Imperial College School of Medicine, Hammersmith Hospital, London, UK
    Search for more papers by this author
    • Group Authorship Information: MR organized and analyzed the data and wrote the manuscript. BP reviewed the data and the manuscript. MW performed the statistical analysis. GV provided technical assistance with the blood samples. JB designed the study, recruited patients from the hematology clinic, and supervised the organization and writing process.

  • Mary J. Ward,

    1. Department of Pediatric Child Development, New York Presbyterian Hospital/Weill Cornell Medical Center, New York
    Search for more papers by this author
    • Group Authorship Information: MR organized and analyzed the data and wrote the manuscript. BP reviewed the data and the manuscript. MW performed the statistical analysis. GV provided technical assistance with the blood samples. JB designed the study, recruited patients from the hematology clinic, and supervised the organization and writing process.

  • Glynnis Villarica,

    1. Division of Pediatric Hematology/Oncology, Platelet Disorder Center, New York Presbyterian Hospital/Weill Cornell Medical Center, New York
    Search for more papers by this author
    • Group Authorship Information: MR organized and analyzed the data and wrote the manuscript. BP reviewed the data and the manuscript. MW performed the statistical analysis. GV provided technical assistance with the blood samples. JB designed the study, recruited patients from the hematology clinic, and supervised the organization and writing process.

  • James B. Bussel

    Corresponding author
    1. Division of Pediatric Hematology/Oncology, Platelet Disorder Center, New York Presbyterian Hospital/Weill Cornell Medical Center, New York
    • Platelet Disorder Center, Division of Hematology/Oncology, Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10021
    Search for more papers by this author
    • Conflict of Interests: James B. Bussel—Research Support: Amgen, GlaxoSmithKline, Eisai, Ligand, Sysmex, Calgene, Shionogi. Consultant/Scientific Advisory Board: Amgen, GSK, Ligand, Shionogi, Eisai. Major Stockholder: Amgen, GSK. Speakers' Bureau: France Foundation. The remaining authors declare no competing financial interests


No abstract is available for this article.

Ancillary